Discover 1,705 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,705
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Detroit MI, Ann Arbor MI, Toledo OH, Peoria IL,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701656
Phase2, Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Location: Detroit MI, Royal Oak MI, Ann Arbor MI, London,
Sponsor: Vedanta Biosciences, Inc.
Sex: All
Age: 12+
Code: NCT06237452
Phase3, Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Detroit MI, Ann Arbor MI, Cleveland OH,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase3, Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for
Advanced Esophageal Adenocarcinoma,
Location: Detroit MI, Dearborn MI, Wyandotte MI, Southfield MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06203600
Phase2, Phase3, Recruiting
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
for
Biliary Tract Cancer
Location: Detroit MI, Ann Arbor MI, London, Toronto,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06282575
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Detroit MI, Grosse Pointe Woods MI, Dearborn MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04269902
Phase3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Detroit MI, Dearborn MI, Royal Oak MI, Brownstown MI,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase3, Recruiting
A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM